A randomized and open-label trial evaluating the addition of pazopanib to lapatinib as first-line therapy in patients with HER2-positive advanced breast cancer (Q45812913)
Jump to navigation
Jump to search
scientific article published on 3 January 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | A randomized and open-label trial evaluating the addition of pazopanib to lapatinib as first-line therapy in patients with HER2-positive advanced breast cancer |
scientific article published on 3 January 2013 |
Statements
1 reference
A randomized and open-label trial evaluating the addition of pazopanib to lapatinib as first-line therapy in patients with HER2-positive advanced breast cancer (English)
1 reference
Stephen R D Johnston
1 reference
Salomon M Stemmer
1 reference
Maria Richie
1 reference
Michael Durante
1 reference
Lini Pandite
1 reference
Vicki Goodman
1 reference
Dennis Slamon
1 reference
3 January 2013
1 reference
137
1 reference
3
1 reference
755-766
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference